Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler
The Hindu — Health · 16 Sep 2026
We couldn't retrieve the full article from The Hindu — Health, so this is the available summary.
The product will be manufactured at subsidiary Aurolife Pharma’s Raleigh facility in North Carolina and expected to be launched in upcoming quarters.
Related articles
India · The Hindu — Health · 4 hours agoEbola reminder of urgent need to finish pandemic treaty: WHO chief
Pointing to several recent deadly disease outbreaks, he stressed that completing a pandemic treaty was "about protecting people"
Read full article
India · The Hindu — Health · 4 hours agoVietnam scraps child organ donors proposal after backlash
The newly revised draft still allows living minors to donate regenerative tissue, for bone marrow or stem cell transplants, to family members when no…
Read full article
India · The Hindu — Health · 6 hours agoOocyte racket in Telangana: Women paid ₹20,000 as operators made around ₹3 lakh per cycle
Police probe alleged exploitation of 43 women, including possible forged consent documents and illegal commissions, while examining recruitment networks, payment trails and the role…
Read full article